An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia

Pegfilgrastim in Patients With Alcoholic Hepatitis

The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study

A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)

Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Clostridium Difficile Vaccine Efficacy Trial

A Pilot Trial of Safety and Efficacy of Telaprevir +Peginterferon +Ribavirin +Vitamin D3 v. Telaprevir +Peginterferon +Ribavirin Among Treatment-naive Veterans With Genotype 1 Hepatitis C Virus